Sort
39,280 grants matching “leukemia”
The Clathrin Coated Vesicle Cycle
$541,714Sandra L. Schmid · Scripps Research Institute, The · R01 · FY2011 · MH
Epigenetic mechanism in mammalian kidney development and tumorigenesis
$541,647Liling Wan · University Of Pennsylvania · R01 · FY2025 · CA
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
$541,616Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2018 · HL
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer
$541,500Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Regulation of HTLV-I Transcription
$541,495John N. Brady · Basic Sciences · Z01 · FY2007 · CA
Using spatial, single-cell genomic recording to investigate age-associated clonal hematopoiesis
$541,387Rong Lu · University Of Southern California · R01 · FY2023 · AG
Chromatin assembly and formaldehyde toxicity
$541,277Chunyuan Jin · New York University School Of Medicine · R01 · FY2024 · ES
The Role of PHF6 in HSC self-renewal and myeloid expansion
$541,264Vikram R. Paralkar · University Of Pennsylvania · R01 · FY2023 · HL
Targeting Tumors with NF1 Loss
$541,146Yolanda Sanchez · Dartmouth College · R01 · FY2018 · NS
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$541,142Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2023 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$541,142Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2022 · CA
NOVEL LENTIVIRAL PSEUDOTYPES
$541,025James K. Willson · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · HL
Novel targeted therapy to reduce health disparities in pediatric leukemia
$541,022Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · CA
Novel targeted therapy to reduce health disparities in pediatric leukemia
$541,022Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
Transduction of Schistosoma mansoni by pseudotyped retrovirus
$540,978Paul J Brindley · George Washington University · R01 · FY2010 · AI
Predictors of Systemic Exposure to Oral 6MP During Maintenance in Adolescentsand Young Adults with Acute Lymphoblastic Leukemia
$540,972Julie Anna Wolfson · University Of Alabama At Birmingham · R01 · FY2025 · CA
The Molecular Pathology of Myeloproliferative Disease
$540,938Jonathan D. Licht · Northwestern University At Chicago · R01 · FY2007 · HL
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2021 · CA
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$540,797Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2020 · CA
Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography
$540,775Lei Xing · Stanford University · R01 · FY2013 · EB
Transcriptional Repression and Activation by YY1
$540,705Yang Shi · Harvard Medical School · R01 · FY2009 · GM
Experimental Therapeutics
$540,700Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2012 · CA
Cytokine control of hematopoiesis and leukemias
$540,680Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
STEM CELL SURVIVAL CLONAL ADAPTATION AND CARCINOGENESIS IN FANCONI ANEMIA
$540,570Grover Carlton Bagby · Oregon Health & Science University · P01 · FY2007 · HL
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$540,466Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2023 · CA